Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Fadi Braiteh, Michael C. Cerio


MolecularHealth announced that Fadi Braiteh has joined its advisory board. Braiteh is an oncologist with Comprehensive Cancer Centers of Nevada, specializing in gastro-intestinal, digestive system, and breast cancers.

He has received a number of awards for his work in cancer, including the 2009 Susan G. Komen Scholar-In-Training Award, the 2007 Jesse Jones Fellowship in Cancer Education Award, and the 2005 and 2006 ASCO Foundation Merit Awards.

Signal Genetics announced it has appointed Michael C. Cerio its Senior Vice President of commercial strategy and business development.

Cerio has worked in business development in the diagnostics and biotech industry for 15 years, most recently as an independent consultant with the life science venture capital firm MPM Capital. Prior to that, he served as Consulting CEO for Modulation Therapies and President and CEO of Oncolome Diagnostics. Cerio also worked at Genzyme Corporation, BG Medicine and Genaissance Pharmaceuticals.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.